Hem › Urotelial (övergångscells-)karcinom › Texas › Austin
Kliniska studier för Urotelial (övergångscells-)karcinom i Austin, TX
10 studier för Urotelial (övergångscells-)karcinom söker deltagare vid platser i och runt Austin (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RekryterarFas 1
- NEXT Austin, Austin
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RekryterarFas 1
- Exelixis Clinical Site #46, Austin
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
RekryterarFas 3
- Texas Oncology, Austin
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
RekryterarFas 1/2
- Texas Oncology - Central/South Texas, Austin
- Texas Oncology - Central/South Texas, Austin
- Texas Oncology - Central/South Texas, Austin
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RekryterarFas 3
- USO-Texas Oncology-Central/South Texas, Austin
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
RekryterarFas 3
- Texas Urology Specialists-Austin, Austin
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
RekryterarFas 1
- NEXT Oncology, Austin, Austin
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Rekryterar
- Austin Urology Institute, Austin
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
RekryterarFas 1
- NEXT Oncology, Austin, TX 78758
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
RekryterarFas 1
- Dren Investigational Site, Austin
Urotelial (övergångscells-)karcinom-studier i andra städer
- Nashville, TN23 studier
- New York City, NY22 studier
- Dallas, TX18 studier
- Edison, NJ18 studier
- Houston, TX18 studier
- Los Angeles, CA17 studier
- Queens, NY15 studier
- Chicago, IL14 studier
- Arlington, VA12 studier
- San Antonio, TX11 studier
- Boston, MA11 studier
- Orange, CA10 studier
Andra studier i Austin
- Icke-småcellig lungcancer30 studier
- Cancer (alla typer)20 studier
- Övervikt20 studier
- Metastaserande cancer19 studier
- Kolorektal cancer19 studier
- Hjärtsvikt18 studier
- Bröstcancer18 studier
- Övervikt18 studier
- Äggstockscancer17 studier
- Endometriecancer15 studier
- Prostatacancer15 studier
- Depression14 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.